---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-013357"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2024-10-17T23:59:59+00:00"
generated_at: "2026-05-30T13:02:14.234961+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Capricor Therapeutics prices ~$75M public offering of 4.4M shares at $17/sh

## Summary
- Gross proceeds ~$75M from 4,412,000 shares at $17.00/sh; underwriters have 30-day option for up to 661,800 additional shares.
- Offering expected to close October 18, 2024; Piper Sandler and Oppenheimer act as joint book-running managers.
- Net proceeds to fund continued product candidate development, manufacturing, working capital, and general corporate purposes.
- Offering made under effective Form S-3 shelf registration; prospectus supplement filed October 16, 2024.

## SEC filing metadata
- accession: 0001558370-24-013357
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2024-10-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000155837024013357/0001558370-24-013357-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000155837024013357/capr-20241016x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-013357
- JSON: https://secwatch.observer/filing/0001558370-24-013357.json
- Plain text: https://secwatch.observer/filing/0001558370-24-013357.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.